全球 DNA 合成市场规模、份额、成长分析（按服务类型、按应用、按最终用户）- 产业预测，2023-2030 年

2022年全球DNA合成市场规模为29亿美元，从2023年的34.6亿美元成长到2031年的145.3亿美元，预测期内（2024-2031年）复合年增长率为19.63%，预计将增长换成美元。

由于其在製药、生物技术和遗传学研究等各个领域的重要作用，全球 DNA 合成市场正在显着成长。研究人员和生物技术公司越来越多地利用 DNA 合成服务来创建 DNA 序列，用于从药物开发到基因工程的广泛应用。对合成生物学工具不断增长的需求、个人化医疗的出现以及基因编辑技术的进步推动了这个市场的扩张。此外，DNA 合成服务有助于实验室中的快速原型製作和实验，促进创新并加快科学突破的步伐。随着生物技术和医疗领域的不断发展，DNA 合成市场有望对基因组学和分子生物学的发展轨迹产生重大影响。

目录

执行摘要

• 市场概况
• 转型

调查方法

• 资讯采购
• 次要和主要资料来源
• 市场规模估算
• 市场假设与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管环境
• 波特的分析
• 对未来中断的特殊考虑

全球 DNA 合成市场：依服务类型

• 市场概况
• 基因合成
• 寡核苷酸合成

DNA 合成的全球市场：依应用分类

• 市场概况
• 研究与开发
• 治疗

全球 DNA 合成市场：依最终用户分类

• 市场概况
• 生物製药公司
• 学术研究所
• 受託研究机构

全球 DNA 合成市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2021年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2021年）

主要企业简介

• 赛默飞世尔科技公司（美国）
• Twist Bioscience（美国）
• Bioneer 公司（韩国）
• 伊顿生物科学（美国）
• LGC Biosearch Technologies（美国）
• IBA 有限公司（德国）
• Eurofins Scientific（卢森堡）
• Integrated DNA Technologies, Inc.（美国）
• Quintara Biosciences（美国）
• 金斯瑞生物科技股份有限公司 (中国)
• 安捷伦科技（美国）
• 默克公司（德国）
• 欧根泰克（比利时）
• Cambio 有限公司（英国）
• Biomatik（加拿大）

Global DNA Synthesis Market size was valued at USD 2.90 Billion in 2022 and is poised to grow from USD 3.46 Billion in 2023 to USD 14.53 Billion by 2031, at a CAGR of 19.63% during the forecast period (2024-2031).

The global DNA synthesis market is witnessing notable growth owing to its crucial role across various sectors including pharmaceuticals, biotechnology, and genetics research. Researchers and biotech firms are increasingly turning to DNA synthesis services to create tailored DNA sequences for a broad array of applications, spanning from drug development to genetic manipulation. This market's expansion is fuelled by the escalating demand for synthetic biology tools, the emergence of personalized medicine, and the ongoing advancements in gene editing technologies. Furthermore, DNA synthesis services facilitate swift prototyping and experimentation in laboratories, fostering innovation and expediting the pace of scientific breakthroughs. As the biotechnology and healthcare sectors continue to progress, the DNA synthesis market stands ready to exert significant influence on the trajectory of genomics and molecular biology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global DNA Synthesis and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global DNA Synthesis Market Segmental Analysis

The global DNA synthesis market is segmented on the basis of Service type, Application, End-user, and region. Based on service type the market is segmented as Gene Synthesis, Oligonucleotide Synthesis. On the basis of application, the market is segmented as Research and Development, Therapeutics. Based on end-user, it is segregated into Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global DNA Synthesis Market

One of the primary factors propelling the DNA synthesis market is the ongoing progress in genetic engineering technologies. Breakthroughs such as CRISPR-Cas9 and other gene-editing methods have notably heightened the need for customized DNA sequences, thereby stimulating the expansion of DNA synthesis services. Given the necessity for precise and tailored DNA constructs in their endeavours, researchers and biotech firms consider DNA synthesis an indispensable element of advanced genetic engineering initiatives.

Restraints in the Global DNA Synthesis Market

A significant challenge in the DNA synthesis sector is the strict regulatory landscape. Rigorous regulations and supervision concerning the synthesis and application of genetic materials, particularly in gene editing and biotechnology, can erect obstacles to entering the market and impede research and development endeavours. While these regulations are crucial for ethical and safety considerations, they can present hurdles for businesses operating in this domain.

Market Trends of the Global DNA Synthesis Market

A significant trend in the DNA synthesis sector is the ongoing progress in gene editing technologies, exemplified by CRISPR-Cas9. These advancements are spurring the need for customized DNA sequences, facilitating precise genetic alterations across various domains like therapeutic research and agriculture. With gene editing tools becoming increasingly accessible and adaptable, the DNA synthesis market is positioned for continuous expansion, meeting the changing demands of researchers and biotech entities.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global DNA Synthesis Market by Service Type

• Market Overview
• Gene Synthesis
• Oligonucleotide Synthesis

Global DNA Synthesis Market by Application

• Market Overview
• Research And Development
• Therapeutics

Global DNA Synthesis Market by End-user

• Market Overview
• Biopharmaceutical Companies
• Academic and Research Institutes
• Contract Research Organizations

Global DNA Synthesis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eton Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quintara Biosciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurogentec (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambio Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomatik (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments